199 related articles for article (PubMed ID: 22589443)
1. Effects of palmitoylethanolamide on aqueous humor outflow.
Kumar A; Qiao Z; Kumar P; Song ZH
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4416-25. PubMed ID: 22589443
[TBL] [Abstract][Full Text] [Related]
2. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
Qiao Z; Kumar A; Kumar P; Song ZH
Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
[TBL] [Abstract][Full Text] [Related]
3. Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility.
Njie YF; Kumar A; Qiao Z; Zhong L; Song ZH
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1999-2005. PubMed ID: 16639008
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humor outflow effects of 2-arachidonylglycerol.
Njie YF; He F; Qiao Z; Song ZH
Exp Eye Res; 2008 Aug; 87(2):106-14. PubMed ID: 18597752
[TBL] [Abstract][Full Text] [Related]
5. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
Zhong L; Geng L; Njie Y; Feng W; Song ZH
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1988-92. PubMed ID: 15914613
[TBL] [Abstract][Full Text] [Related]
6. N-arachidonylethanolamide-induced increase in aqueous humor outflow facility.
Njie YF; Qiao Z; Xiao Z; Wang W; Song ZH
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4528-34. PubMed ID: 18539938
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
[TBL] [Abstract][Full Text] [Related]
8. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility.
Mettu PS; Deng PF; Misra UK; Gawdi G; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2263-71. PubMed ID: 15223804
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
11. The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.
Wallace VC; Segerdahl AR; Lambert DM; Vandevoorde S; Blackbeard J; Pheby T; Hasnie F; Rice AS
Br J Pharmacol; 2007 Aug; 151(7):1117-28. PubMed ID: 17558434
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids protect the rat isolated heart against ischaemia.
Lépicier P; Bouchard JF; Lagneux C; Lamontagne D
Br J Pharmacol; 2003 Jun; 139(4):805-15. PubMed ID: 12813004
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork.
Rao PV; Peterson YK; Inoue T; Casey PJ
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2464-71. PubMed ID: 18316706
[TBL] [Abstract][Full Text] [Related]
14. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
Alsalem M; Haddad M; Aldossary SA; Kalbouneh H; Altarifi A; Jaffal SM; Abbas MA; Aldaoud N; El-Salem K
Inflammopharmacology; 2019 Dec; 27(6):1131-1142. PubMed ID: 30945071
[TBL] [Abstract][Full Text] [Related]
15. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
16. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
17. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
18. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
19. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
Ellis DZ; Dismuke WM; Chokshi BM
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1808-13. PubMed ID: 19074804
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
